TWO SIGMA INVESTMENTS, LP - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 68 filers reported holding EVELO BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$55,000
-84.4%
26,116
-74.9%
0.00%
-100.0%
Q1 2022$352,000
+334.6%
103,926
+679.6%
0.00%
Q4 2021$81,000
-31.4%
13,330
-20.2%
0.00%
Q3 2021$118,000
-89.7%
16,700
-80.0%
0.00%
-100.0%
Q2 2021$1,147,000
-22.1%
83,494
-39.4%
0.00%
-25.0%
Q1 2021$1,473,000137,6960.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders